SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-023501
Filing Date
2022-02-15
Accepted
2022-02-15 07:01:07
Documents
14
Period of Report
2022-02-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226644d1_8k.htm   iXBRL 8-K 36212
2 EXHIBIT 99.1 tm226644d1_ex99-1.htm EX-99.1 23237
6 GRAPHIC tm226644d1_ex99-1img001.jpg GRAPHIC 10177
  Complete submission text file 0001104659-22-023501.txt   253319

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA acur-20220214.xsd EX-101.SCH 3039
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20220214_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20220214_pre.xml EX-101.PRE 22599
8 EXTRACTED XBRL INSTANCE DOCUMENT tm226644d1_8k_htm.xml XML 3502
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10113 | Film No.: 22637010
SIC: 2834 Pharmaceutical Preparations